Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

428798

registered interest
date	17/11/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer given by the Parliamentary Under-Secretary of State for Care Quality during Oral Questions on 17 November 2015 on the establishment of a working party to examine issues regarding the availability of off-patent, repurposed drugs, when the working party was established; what the working party's scope and terms of reference are; which organisations and individuals have been invited to join the working party; and when the next meeting of the working party will be convened.
tabling member constituency	Torfaen
tabling member printed	Nick Thomas-Symonds
uin	16729
answer	answer is ministerial correction date of answer 20/11/2015 answer text <p>The Government has not established a working party in relation to the Off-Patent Drugs Bill. We did hold a roundtable event in February 2015 with key stakeholders including charities and agreed several follow up actions. We have now agreed additional further actions:</p><p>- arrange a further roundtable event specifically for those charities who would like to explore the Bill in more detail;</p><p>- input in to the work of the Off-Patent Drugs Bill All Party Parliamentary Group; and</p><p>- hold a Ministerial drop-in session on 30 November, for those who would like to discuss the Bill further. This will be hosted by myself.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 20/11/2015 14:51:05 answering member 4020 label Biography information for George Freeman
tabling member	4479 label Biography information for Nick Thomas-Symonds

416690

registered interest
date	04/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Licensing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department has taken to act upon the outcomes of the stakeholder roundtable discussion it convened on 11 February 2015 on access to off-patent drugs.
tabling member constituency	Torfaen
tabling member printed	Nick Thomas-Symonds
uin	8971
answer	answer is ministerial correction date of answer 09/09/2015 answer text <p>The Department convened a roundtable event on 11 February 2015 to discuss what action, could most expeditiously be taken to ensure that robust evidence about new uses for existing drugs is produced, disseminated and then used to inform clinical decision making about these medicines.</p><p> </p><p> </p><p> </p><p>A number of areas were identified where further work could help improve matters, including:</p><p> </p><p> </p><p> </p><p>- supporting clinicians to identify the latest robust evidence on patient care and take it up in their own practice; and</p><p> </p><p>- supporting and mapping clear pathways for innovators and those who want to &quot;re-purpose&quot; drugs.</p><p> </p><p> </p><p> </p><p>Officials have since been engaging with stakeholders to progress outputs associated with this event.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 8970 8974 question first answered 09/09/2015 16:26:29 answering member 4020 label Biography information for George Freeman
tabling member	4479 label Biography information for Nick Thomas-Symonds

416692

registered interest
date	04/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Licensing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with which organisations and individuals (a) Ministers and (b) officials in his Department have discussed the availability of repurposed off-patent drugs on the NHS since 12 February 2014.
tabling member constituency	Torfaen
tabling member printed	Nick Thomas-Symonds
uin	8973
answer	answer is ministerial correction date of answer 09/09/2015 answer text <p>Following the 11 February 2015 Roundtable Event on <em>‘Translating Evidence in to Clinical Practice’</em>, officials are continuing to work with key stakeholders including charities, health professional networks, the General Medical Council, the National Institute for Health and Care Excellence and the Medicines &amp; Healthcare products Regulatory Agency. Officials have since been engaging with stakeholders to progress outputs associated with this event.</p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 09/09/2015 16:00:15 answering member 4020 label Biography information for George Freeman
tabling member	4479 label Biography information for Nick Thomas-Symonds

416693

registered interest
date	04/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Licensing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what progress has been made in implementing non-legislative measures to provide routine access on the NHS to off-patent drugs that have been proven to be clinically effective for new indications.
tabling member constituency	Torfaen
tabling member printed	Nick Thomas-Symonds
uin	8974
answer	answer is ministerial correction date of answer 09/09/2015 answer text <p>The Department convened a roundtable event on 11 February 2015 to discuss what action, could most expeditiously be taken to ensure that robust evidence about new uses for existing drugs is produced, disseminated and then used to inform clinical decision making about these medicines.</p><p> </p><p> </p><p> </p><p>A number of areas were identified where further work could help improve matters, including:</p><p> </p><p> </p><p> </p><p>- supporting clinicians to identify the latest robust evidence on patient care and take it up in their own practice; and</p><p> </p><p>- supporting and mapping clear pathways for innovators and those who want to &quot;re-purpose&quot; drugs.</p><p> </p><p> </p><p> </p><p>Officials have since been engaging with stakeholders to progress outputs associated with this event.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 8970 8971 question first answered 09/09/2015 16:26:29 answering member 4020 label Biography information for George Freeman
tabling member	4479 label Biography information for Nick Thomas-Symonds

416694

registered interest
date	04/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Licensing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the outcome was of the stakeholder roundtable discussion on off-patent drugs convened by his Department on 11 February 2015.
tabling member constituency	Torfaen
tabling member printed	Nick Thomas-Symonds
uin	8970
answer	answer is ministerial correction date of answer 09/09/2015 answer text <p>The Department convened a roundtable event on 11 February 2015 to discuss what action, could most expeditiously be taken to ensure that robust evidence about new uses for existing drugs is produced, disseminated and then used to inform clinical decision making about these medicines.</p><p> </p><p> </p><p> </p><p>A number of areas were identified where further work could help improve matters, including:</p><p> </p><p> </p><p> </p><p>- supporting clinicians to identify the latest robust evidence on patient care and take it up in their own practice; and</p><p> </p><p>- supporting and mapping clear pathways for innovators and those who want to &quot;re-purpose&quot; drugs.</p><p> </p><p> </p><p> </p><p>Officials have since been engaging with stakeholders to progress outputs associated with this event.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 8971 8974 question first answered 09/09/2015 16:26:29 answering member 4020 label Biography information for George Freeman
tabling member	4479 label Biography information for Nick Thomas-Symonds

386178

registered interest
date	29/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with Health Ministers in the devolved administrations on increasing research into pancreatic cancer across the UK.
tabling member constituency	Torfaen
tabling member printed	Nick Thomas-Symonds
uin	4530
answer	answer is ministerial correction date of answer 02/07/2015 answer text <p>My Rt. hon. Friend the Secretary of State for Health has had no such discussions.</p><p> </p><p> </p><p> </p><p>Expenditure by the Department’s National Institute for Health Research (NIHR) on cancer research is shown in the following table.</p><p> </p><p> </p><p> </p><p>£ million</p><p> </p><table><tbody><tr><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td><p>100.9</p></td><td><p>104.1</p></td><td><p>133.2</p></td><td><p>129.9</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>A figure for 2014/15 is not yet available. Data is not available for total NIHR research spend on specific cancer sites as site-specific data cannot be disaggregated from total expenditure through NIHR research infrastructure funding streams.</p><p> </p><p> </p><p> </p><p>The NIHR welcomes funding applications for research into any aspect of human health, including pancreatic cancer. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p><p> </p><p> </p><p>The NIHR has recently awarded £290,986 to University College London Hospitals NHS Foundation Trust for a phase II trial of endoscopic ultrasound-guided radiofrequency ablation of cystic tumours of the pancreas.</p><p> </p><p> </p><p> </p><p>The NIHR Research Design Service is available to help prospective applicants, including applicants in pancreatic cancer research, develop and design high-quality proposals for submission to NIHR itself and also to other national, peer-reviewed funding competitions for applied health or social care research. The service provides expert advice to researchers on all aspects of preparing grant applications in these fields, including advice on research methodology, clinical trials, patient involvement, and ethics and governance.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 4524 4525 question first answered 02/07/2015 12:13:02 answering member 4020 label Biography information for George Freeman
tabling member	4479 label Biography information for Nick Thomas-Symonds